Journal articles on the topic 'MuscleBlind Like (MBNL)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'MuscleBlind Like (MBNL).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Bargiela, Ariadna, Maria Sabater-Arcis, Jorge Espinosa-Espinosa, Miren Zulaica, Adolfo Lopez de Munain, and Ruben Artero. "Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models." Proceedings of the National Academy of Sciences 116, no. 50 (November 21, 2019): 25203–13. http://dx.doi.org/10.1073/pnas.1820297116.
Full textVoss, Dillon, Anthony Sloan, Eli Bar, and Eli Bar. "TAMI-49. THE ALTERNATIVE SPLICING FACTOR MBNL1 INHIBITS GLIOBLASTOMA TUMOR INITIATION AND PROGRESSION BY REDUCING HYPOXIA-INDUCED STEMNESS." Neuro-Oncology 22, Supplement_2 (November 2020): ii223—ii224. http://dx.doi.org/10.1093/neuonc/noaa215.936.
Full textOverby, Sarah, Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-Martínez, Nerea Moreno, Juan Fernández-Costa, Jordina Balaguer-Trias, et al. "BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice." Pharmaceutics 15, no. 4 (March 31, 2023): 1118. http://dx.doi.org/10.3390/pharmaceutics15041118.
Full textYadava, Ramesh S., Mahua Mandal, and Mani S. Mahadevan. "Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration." International Journal of Molecular Sciences 25, no. 5 (February 26, 2024): 2687. http://dx.doi.org/10.3390/ijms25052687.
Full textGonzález, Àlex L., Daniel Fernández-Remacha, José Ignacio Borrell, Jordi Teixidó, and Roger Estrada-Tejedor. "Cognate RNA-Binding Modes by the Alternative-Splicing Regulator MBNL1 Inferred from Molecular Dynamics." International Journal of Molecular Sciences 23, no. 24 (December 18, 2022): 16147. http://dx.doi.org/10.3390/ijms232416147.
Full textVerbeeren, Jens, Joana Teixeira, and Susana M. D. A. Garcia. "The Muscleblind-like protein MBL-1 regulates microRNA expression in Caenorhabditis elegans through an evolutionarily conserved autoregulatory mechanism." PLOS Genetics 19, no. 12 (December 22, 2023): e1011109. http://dx.doi.org/10.1371/journal.pgen.1011109.
Full textTerenzi, Fulvia, and Andrea N. Ladd. "Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity." RNA Biology 7, no. 1 (January 2010): 43–55. http://dx.doi.org/10.4161/rna.7.1.10401.
Full textLópez-Martínez, Andrea, Patricia Soblechero-Martín, Laura de-la-Puente-Ovejero, Gisela Nogales-Gadea, and Virginia Arechavala-Gomeza. "An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I." Genes 11, no. 9 (September 22, 2020): 1109. http://dx.doi.org/10.3390/genes11091109.
Full textSznajder, Łukasz J., and Maurice S. Swanson. "Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy." International Journal of Molecular Sciences 20, no. 13 (July 9, 2019): 3365. http://dx.doi.org/10.3390/ijms20133365.
Full textTanner, Matthew K., Zhenzhi Tang, and Charles A. Thornton. "Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy." Nucleic Acids Research 49, no. 4 (January 27, 2021): 2240–54. http://dx.doi.org/10.1093/nar/gkab022.
Full textLópez Castel, Arturo, Sarah Joann Overby, and Rubén Artero. "MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy." International Journal of Molecular Sciences 20, no. 22 (November 9, 2019): 5600. http://dx.doi.org/10.3390/ijms20225600.
Full textHolm, Frida, Eva Hellqvist, Cayla N. Mason, Shawn A. Ali, Nathaniel Delos-Santos, Christian L. Barrett, Hye-Jung Chun, et al. "Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal." Proceedings of the National Academy of Sciences 112, no. 50 (November 30, 2015): 15444–49. http://dx.doi.org/10.1073/pnas.1506943112.
Full textHuang, Hu, Karl J. Wahlin, Minda McNally, Natasha D. Irving, and Ruben Adler. "Developmental regulation of muscleblind-like (MBNL) gene expression in the chicken embryo retina." Developmental Dynamics 237, no. 1 (January 2008): 286–96. http://dx.doi.org/10.1002/dvdy.21408.
Full textTabaglio, Tommaso, Diana HP Low, Winnie Koon Lay Teo, Pierre Alexis Goy, Piotr Cywoniuk, Heike Wollmann, Jessica Ho, et al. "MBNL1 alternative splicing isoforms play opposing roles in cancer." Life Science Alliance 1, no. 5 (September 7, 2018): e201800157. http://dx.doi.org/10.26508/lsa.201800157.
Full textPenna, Matthew S., Rong-Chi Hu, George G. Rodney, and Thomas A. Cooper. "The role ofLimch1alternative splicing in skeletal muscle function." Life Science Alliance 6, no. 6 (March 28, 2023): e202201868. http://dx.doi.org/10.26508/lsa.202201868.
Full textXie, Jianxin, Wei Zou, Madina Tugizova, Kang Shen, and Xiangming Wang. "MBL-1 and EEL-1 affect the splicing and protein levels of MEC-3 to control dendrite complexity." PLOS Genetics 19, no. 9 (September 20, 2023): e1010941. http://dx.doi.org/10.1371/journal.pgen.1010941.
Full textLi, Moyi, Yan Zhuang, Ranjan Batra, James D. Thomas, Mao Li, Curtis A. Nutter, Marina M. Scotti, et al. "HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy." Proceedings of the National Academy of Sciences 117, no. 10 (February 21, 2020): 5472–77. http://dx.doi.org/10.1073/pnas.1907297117.
Full textStepniak-Konieczna, Ewa, Patryk Konieczny, Piotr Cywoniuk, Julia Dluzewska, and Krzysztof Sobczak. "AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1." Nucleic Acids Research 48, no. 5 (January 22, 2020): 2531–43. http://dx.doi.org/10.1093/nar/gkaa007.
Full textWang, Eric T., Daniel Treacy, Katy Eichinger, Adam Struck, Joseph Estabrook, Hailey Olafson, Thomas T. Wang, et al. "Transcriptome alterations in myotonic dystrophy skeletal muscle and heart." Human Molecular Genetics 28, no. 8 (December 17, 2018): 1312–21. http://dx.doi.org/10.1093/hmg/ddy432.
Full textHolm, Frida Linnea, Eva Hellqvist, Cayla N. Mason, Shawn Ali, Nathaniel Delos Santos, Christian Barrett, Hye-Jung Chun, et al. "Reversion to an Embryonic Alternative Splicing Program Enhances Leukemia Stem Cell Self-Renewal." Blood 126, no. 23 (December 3, 2015): 1227. http://dx.doi.org/10.1182/blood.v126.23.1227.1227.
Full textIhsan, M. O., D. M. Tan, U. Muniasamy, M. S. Ong, X. Y. Lin, C. N. Lee, R. Dorajoo, and V. Sorokin. "Muscleblind-like (MBNL) protein family overexpression lead to pro-synthetic phenotype modulation of arterial human vascular smooth muscle cells in diabetes mellitus." Atherosclerosis 355 (August 2022): 205–6. http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.821.
Full textJu, Woong, Hye Youn Sung, and Jung-Hyuck Ahn. "Abstract B091: Overexpression of Muscleblind Like Splicing Regulator 2 (MBNL2) enhances cisplatin resistance in ovarian cancer." Molecular Cancer Therapeutics 22, no. 12_Supplement (December 1, 2023): B091. http://dx.doi.org/10.1158/1535-7163.targ-23-b091.
Full textChen, Jiaorong, Jiaqi Wang, Jingyi Qian, Mengying Bao, Xin Zhang, and Zheng Huang. "MBNL1 Suppressed Cancer Metastatic of Skin Squamous Cell Carcinoma Via by TIAL1/MYOD1/Caspase-9/3 Signaling Pathways." Technology in Cancer Research & Treatment 20 (January 1, 2021): 153303382096075. http://dx.doi.org/10.1177/1533033820960755.
Full textTran, Hélène, Nathalie Gourrier, Camille Lemercier-Neuillet, Claire-Marie Dhaenens, Audrey Vautrin, Francisco José Fernandez-Gomez, Ludovic Arandel, et al. "Analysis of Exonic Regions Involved in Nuclear Localization, Splicing Activity, and Dimerization of Muscleblind-like-1 Isoforms." Journal of Biological Chemistry 286, no. 18 (March 18, 2011): 16435–46. http://dx.doi.org/10.1074/jbc.m110.194928.
Full textCheng, Albert W., Jiahai Shi, Piu Wong, Katherine L. Luo, Paula Trepman, Eric T. Wang, Heejo Choi, Christopher B. Burge, and Harvey F. Lodish. "Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis." Blood 124, no. 4 (July 24, 2014): 598–610. http://dx.doi.org/10.1182/blood-2013-12-542209.
Full textSun, Xueqin, Xinghua Diao, Xiaolin Zhu, Xuexue Yin, and Guangying Cheng. "Nanog-mediated stem cell properties are critical for MBNL3-associated paclitaxel resistance of ovarian cancer." Journal of Biochemistry 169, no. 6 (February 18, 2021): 747–56. http://dx.doi.org/10.1093/jb/mvab021.
Full textGates, Devika P., Leslie A. Coonrod, and J. Andrew Berglund. "Autoregulated Splicing of muscleblind-like 1 (MBNL1) Pre-mRNA." Journal of Biological Chemistry 286, no. 39 (August 9, 2011): 34224–33. http://dx.doi.org/10.1074/jbc.m111.236547.
Full textCai, Jin, Ningchao Wang, Guanglan Lin, Haowei Zhang, Weidong Xie, Yaou Zhang, and Naihan Xu. "MBNL2 Regulates DNA Damage Response via Stabilizing p21." International Journal of Molecular Sciences 22, no. 2 (January 14, 2021): 783. http://dx.doi.org/10.3390/ijms22020783.
Full textLi, Yanbing, Min Zong, Xiaonan Guan, Xuejiao Wu, Guiling Ma, Yu Wei, and Zhi Li. "MBNL1-AS1 Promotes Hypoxia-Induced Myocardial Infarction via the miR-132-3p/RAB14/CAMTA1 Axis." Oxidative Medicine and Cellular Longevity 2023 (February 4, 2023): 1–12. http://dx.doi.org/10.1155/2023/3308725.
Full textYokoyama, Shingo, Yoshitaka Ohno, Tatsuro Egawa, Kazuya Ohashi, Rika Ito, Huascar Pedro Ortuste Quiroga, Tomohiro Yamashita, and Katsumasa Goto. "MBNL1-Associated Mitochondrial Dysfunction and Apoptosis in C2C12 Myotubes and Mouse Skeletal Muscle." International Journal of Molecular Sciences 21, no. 17 (September 2, 2020): 6376. http://dx.doi.org/10.3390/ijms21176376.
Full textHao, Minqi, Kevan Akrami, Ke Wei, Carlos De Diego, Nam Che, Jeong-Hee Ku, James Tidball, Michael C. Graves, Perry B. Shieh, and Fabian Chen. "Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy." Developmental Dynamics 237, no. 2 (January 21, 2008): 403–10. http://dx.doi.org/10.1002/dvdy.21428.
Full textSeachrist, Darcie D., Molly M. Hannigan, Natasha N. Ingles, Bryan M. Webb, Kristen L. Weber-Bonk, Peng Yu, Gurkan Bebek, et al. "The transcriptional repressor BCL11A promotes breast cancer metastasis." Journal of Biological Chemistry 295, no. 33 (June 23, 2020): 11707–19. http://dx.doi.org/10.1074/jbc.ra120.014018.
Full textTeplova, Marianna, and Dinshaw J. Patel. "Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1." Nature Structural & Molecular Biology 15, no. 12 (November 30, 2008): 1343–51. http://dx.doi.org/10.1038/nsmb.1519.
Full textLee, Johanna E., and Thomas A. Cooper. "Pathogenic mechanisms of myotonic dystrophy." Biochemical Society Transactions 37, no. 6 (November 19, 2009): 1281–86. http://dx.doi.org/10.1042/bst0371281.
Full textRamon-Duaso, Carla, Thomas Gener, Marta Consegal, Cristina Fernández-Avilés, Juan José Gallego, Laura Castarlenas, Maurice S. Swanson, et al. "Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression." Cerebral Cortex 29, no. 7 (July 27, 2018): 2978–97. http://dx.doi.org/10.1093/cercor/bhy164.
Full textBallester-Lopez, Alfonsina, Judit Núñez-Manchón, Emma Koehorst, Ian Linares-Pardo, Miriam Almendrote, Giuseppe Lucente, Nicolau Guanyabens, et al. "Three-dimensional imaging in myotonic dystrophy type 1." Neurology Genetics 6, no. 4 (July 21, 2020): e484. http://dx.doi.org/10.1212/nxg.0000000000000484.
Full textSmith, Kelly P., Meg Byron, Carol Johnson, Yigong Xing, and Jeanne B. Lawrence. "Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains." Journal of Cell Biology 178, no. 6 (September 10, 2007): 951–64. http://dx.doi.org/10.1083/jcb.200706048.
Full textHerrendorff, Ruben, Maria Teresa Faleschini, Adeline Stiefvater, Beat Erne, Tatiana Wiktorowicz, Frances Kern, Matthias Hamburger, Olivier Potterat, Jochen Kinter, and Michael Sinnreich. "Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I." Journal of Biological Chemistry 291, no. 33 (June 13, 2016): 17165–77. http://dx.doi.org/10.1074/jbc.m115.710616.
Full textNeault, Nafisa, Aymeric Ravel-Chapuis, Stephen D. Baird, John A. Lunde, Mathieu Poirier, Emiliyan Staykov, Julio Plaza-Diaz, et al. "Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model." International Journal of Molecular Sciences 24, no. 4 (February 14, 2023): 3794. http://dx.doi.org/10.3390/ijms24043794.
Full textLee, Kyung-Soon, Yi Cao, Hanna E. Witwicka, Susan Tom, Stephen J. Tapscott, and Edith H. Wang. "RNA-binding Protein Muscleblind-like 3 (MBNL3) Disrupts Myocyte Enhancer Factor 2 (Mef2) β-Exon Splicing." Journal of Biological Chemistry 285, no. 44 (August 13, 2010): 33779–87. http://dx.doi.org/10.1074/jbc.m110.124255.
Full textNeault, Nafisa, Sean O’Reilly, Aiman Tariq Baig, Julio Plaza-Diaz, Mehrdad Azimi, Faraz Farooq, Stephen D. Baird, and Alex MacKenzie. "High-throughput kinome-RNAi screen identifies protein kinase R activator (PACT) as a novel genetic modifier of CUG foci integrity in myotonic dystrophy type 1 (DM1)." PLOS ONE 16, no. 9 (September 14, 2021): e0256276. http://dx.doi.org/10.1371/journal.pone.0256276.
Full textGurunathan, Arun, Lana S. Itskovich, Jason Clark, Matthew Burwinkel, Nathan Salomonis, Meenakshi Venkatasubramanian, Kashish Chetal, Lynn Lee, and Ashish R. Kumar. "MLL-Fusion Leukemia Dependence on MBNL1 Is Associated with Alternative Splicing of Oncogenic Proteins." Blood 132, Supplement 1 (November 29, 2018): 3883. http://dx.doi.org/10.1182/blood-2018-99-112349.
Full textItskovich, Svetlana S., Jason Clark, James C. Mulloy, Matthew D. Disney, and Ashish R. Kumar. "MBNL1 As a New Therapeutic Target in MLL-Fusion Gene Leukemia." Blood 126, no. 23 (December 3, 2015): 462. http://dx.doi.org/10.1182/blood.v126.23.462.462.
Full textAngelbello, Alicia J., Suzanne G. Rzuczek, Kendra K. Mckee, Jonathan L. Chen, Hailey Olafson, Michael D. Cameron, Walter N. Moss, Eric T. Wang, and Matthew D. Disney. "Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model." Proceedings of the National Academy of Sciences 116, no. 16 (March 29, 2019): 7799–804. http://dx.doi.org/10.1073/pnas.1901484116.
Full textSen, Supriya, Indrani Talukdar, Ying Liu, Joseph Tam, Sita Reddy, and Nicholas J. G. Webster. "Muscleblind-like 1 (Mbnl1) Promotes Insulin Receptor Exon 11 Inclusion via Binding to a Downstream Evolutionarily Conserved Intronic Enhancer." Journal of Biological Chemistry 285, no. 33 (June 2, 2010): 25426–37. http://dx.doi.org/10.1074/jbc.m109.095224.
Full textdeLorimier, Elaine, Melissa N. Hinman, Jeremy Copperman, Kausiki Datta, Marina Guenza, and J. Andrew Berglund. "Pseudouridine Modification Inhibits Muscleblind-like 1 (MBNL1) Binding to CCUG Repeats and Minimally Structured RNA through Reduced RNA Flexibility." Journal of Biological Chemistry 292, no. 10 (January 27, 2017): 4350–57. http://dx.doi.org/10.1074/jbc.m116.770768.
Full textLueck, John D., Ami Mankodi, Maurice S. Swanson, Charles A. Thornton, and Robert T. Dirksen. "Muscle Chloride Channel Dysfunction in Two Mouse Models of Myotonic Dystrophy." Journal of General Physiology 129, no. 1 (December 11, 2006): 79–94. http://dx.doi.org/10.1085/jgp.200609635.
Full textLiu, Weifeng, Wenyuan Lin, and Liangliang Yu. "Long non-coding RNA muscleblind like splicing regulator 1 antisense RNA 1 (LncRNA MBNL1-AS1) promotes the progression of acute myocardial infarction by regulating the microRNA-132-3p/SRY-related high-mobility-group box 4 (SOX4) axis." Bioengineered 13, no. 1 (January 1, 2022): 1424–35. http://dx.doi.org/10.1080/21655979.2021.2018974.
Full textFrison-Roche, Charles, Célia Martin Demier, Steve Cottin, Jeanne Lainé, Ludovic Arandel, Marius Halliez, Mégane Lemaitre, et al. "MBNL deficiency in motor neurons disrupts neuromuscular junction maintenance and gait coordination." Brain, October 26, 2024. http://dx.doi.org/10.1093/brain/awae336.
Full textHildebrandt, Ryan P., Kathryn R. Moss, Aleksandra Janusz-Kaminska, Luke A. Knudson, Lance T. Denes, Tanvi Saxena, Devi Prasad Boggupalli, et al. "Muscleblind-like proteins use modular domains to localize RNAs by riding kinesins and docking to membranes." Nature Communications 14, no. 1 (June 9, 2023). http://dx.doi.org/10.1038/s41467-023-38923-6.
Full text